NSE: AKUMS • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding75.26%
FII Holding1.15%
DII Holding14.40%
Public Holding5.51%
Total Shareholders76,869
As ofDec 2025
View the latest shareholding pattern of Akums Drugs & Pharma (AKUMS) including promoter, FII, DII, and public holdings.
Track AKUMS ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See AKUMS price to book ratio)
Akums Drugs & Pharma (AKUMS) Shareholding Summary
Promoter holding remains unchanged at 75.26% in Dec 2025
FII/FPI have decreased holdings from 2.28% to 1.15% in Dec 2025
DIIs have increased holdings from 9.28% to 14.40% in Dec 2025
Institutional investors have increased holdings from 11.56% to 15.55% in Dec 2025
Public holding has increased from 5.01% to 5.51% in Dec 2025
Number of shareholders increased from 75,365 to 76,869 in Dec 2025
AKUMS Quarterly Ownership Changes
Quarter-over-quarter changes for Akums Drugs & Pharma from Sept 2025 to Dec 2025.
Akums Drugs & Pharma shareholding pattern reveals who owns AKUMS stock and how ownership changes over time. High promoter stakes in AKUMS often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AKUMS trades. AKUMS 52-week chart
Combine AKUMS ownership analysis with price movements and financial performance for a complete investment picture. (See AKUMS price earnings ratio)